Skip to content
SearchStart for free

DEVA PHARMA

ActiveBesloten VennootschapWielsbeke0847.315.091
HealthyThe latest annual accounts show a healthy company.Annual accounts 2025
Full analysisFollow this company

Details

Company details

Enterprise number
0847.315.091
VAT number
BE 0847.315.091
Peppol ID
0208:0847315091
Legal form
Besloten Vennootschap
Start date
03/07/201214 years
Main activity
Activiteiten van holdings 64210
AddressRidder de Ghellinckstraat 28
8710 Wielsbeke
Google MapsApple MapsWaze

Why

Is DEVA PHARMA a healthy company?

Healthy

  • Return on assetsStrong

    The company makes a lot of profit from everything it owns.

    13.7%. Typical in the sector: 4.3%

  • SolvencyStrong

    The company runs largely on its own money, not on debt.

    65.7%. Typical in the sector: 55.8%

  • At risk

    Working capital doesn't cover the need: a risk of payment problems in the short term.

Based on the 2025 annual accounts, filed on 29/06/2026. View the annual accounts at the NBB

Creya method: information, not advice. How we calculate

Sector comparison

How does DEVA PHARMA compare with its sector?

We set every ratio against similar companies, using the National Bank's sector figures.

Compare with the sector

Key figures

Figures over the years

Gross margin 2025
€143,510
+35%
Profit or loss 2025
€93,689
+44%
Equity 2025
€673,541
+16%
Employees (FTE) 2025
Not published
Gross margin 2022–2025+13%
2022202320242025
Key figures per fiscal year
Fiscal year2025202420232022
Income statement
Gross margin€143,510+35%€106,144−33%€159,432+26%€126,555
Operating result€139,987+37%€102,464−34%€156,157+27%€123,381
Profit or loss€93,689+44%€65,053−36%€102,411+33%€77,004
Balance sheet
Equity€673,541+16%€580,852+6%€545,895+12%€489,334
Total assets€1,024,544+4%€980,478−2%€1,003,879+2%€980,333
Filed29/06/202601/07/202502/07/2024In 2023

Amounts as filed with the National Bank. Small companies don't have to publish their revenue. 2022: previous fiscal year, as stated in the 2023 annual accounts.

Management

Who runs DEVA PHARMA?

According to the annual accounts of 29/06/2026.

Directors (1)

  • MURIEL DEBEUCKELAEREDirector

Credit limit

Know how much credit you can safely give this company, before you invoice.

Create an account

Timeline

Filed annual accounts

3 of 3 filed on time since fiscal year 2023

All annual accounts at the NBB
  1. Annual accounts 2023, 2023filed on 02/07/2024, On time
  2. Annual accounts 2024, 2024filed on 01/07/2025, On timeCorrection
  3. Annual accounts 2024, 2024filed on 01/07/2025, On time
  4. Annual accounts 2025, 2025filed on 29/06/2026, On time

Questions

Frequently asked questions about DEVA PHARMA

Is DEVA PHARMA a healthy company?

Healthy. The latest annual accounts show a healthy company. Based on the 2025 annual accounts, filed on 29/06/2026.

What is the revenue of DEVA PHARMA?

DEVA PHARMA doesn't have to publish its revenue. The gross margin was €143,510 in 2025.

How much profit does DEVA PHARMA make?

The result of fiscal year 2025 was €93,689.

Who manages DEVA PHARMA?

According to the annual accounts of 29/06/2026: MURIEL DEBEUCKELAERE.

What is the VAT number of DEVA PHARMA?

The VAT number is BE 0847.315.091. The enterprise number is 0847.315.091.

Where is DEVA PHARMA located?

Ridder de Ghellinckstraat 28, 8710 Wielsbeke.

What is the Peppol ID of DEVA PHARMA?

The Peppol ID is 0208:0847315091.

When was DEVA PHARMA founded?

The start date in the KBO is 03/07/2012.

Sources

Where do these numbers come from?

CreyaThe same rules for every company, from the official figures.
  • Verdict
  • Key figures
  • Sector comparison
How we calculate

Something not right?